Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IDOX PLC Investor Presentation 2020

Apr 20, 2020

7699_ip_2020-04-20_d6ab6a56-7277-40c5-aa34-c38d362acffc.html

Investor Presentation

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

RNS Number : 1688K

IDOX PLC

20 April 2020

A new dawn

Idox presents an unusual investment opportunity - a business deeply embedded in customer markets for many years (even decades) but one also ready to benefit from a major revitalisation, to move with its customers to more modern and higher margin SaaS-based delivery and relatively resilient to Covid-19 pressures.  We provide an overview of the group, and look forward to 2020 delivering on the back of a solid 2019 result.

Click here for full analysis

Subscribe to Progressive's research, which is freely available to every type of investor, and be kept informed about our regular programme of investor engagement. 

About Progressive:

Progressive is an equity research and investor engagement company.  FCA authorised and regulated, the firm has a 15-strong team of highly experienced analysts.  We provide Institutional grade research and connect companies with investors across every sector of the market.

www.progressive-research.com

Broad coverage Analyst calibre
across 12 sectors
Business Services Oil & Gas 15

analysts
with average 20

years
Financials Property experience of
Healthcare Retail
Industrials Technology 30+ techMARK
Investment Trusts Telecoms industry based Extel
Mining Utilities awards StarMine

For further information please contact:

Emily Ritchie

+44 (0) 20 7781 5311

[email protected]

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

NRAKKKBQABKKFQB